Literature DB >> 15464668

Impact of contemporary guideline compliance on risk stratification models for acute coronary syndromes in The Registry of Acute Coronary Syndromes.

Martha Gulati1, Samir Patel, Allan S Jaffe, Anthony J Joseph, James E Calvin.   

Abstract

We compared the predictive value of the Rush score with the Thrombolysis In Myocardial Infarction (TIMI) risk score in unselected patients with an acute coronary syndrome and evaluated the effect of compliance with established guidelines on the accuracy of these models. The Registry of Acute Coronary Syndromes is a retrospective registry of 3,754 consecutive patients (38% women; mean age 67 years) who presented with acute coronary syndrome to the emergency department between April 1, 1999, and December 31, 2000, at 9 hospitals. The primary end point was death, myocardial infarction, or urgent revascularization during hospitalization. Rush classification was based on quartiles of predicted risk of cardiac complication (<2% for class I vs >15% for class IV). The TIMI score was implemented as published. Compliance with guidelines for acute coronary syndrome was assessed with a 4-point scale based on the aggregate use of aspirin, beta blockers, heparin, and glycoprotein IIb/IIIa inhibitors. Fifteen percent of patients met the primary end point. The primary end point rates for TIMI scores 0/1, 2, 3, 4, 5, and 6/7 were 11%, 14%, 13%, 11%, 14%, and 12%, respectively (p = NS). The primary end point rates for Rush classes I, II, III, and IV were 6%, 8%, 9%, and 17%, respectively (p <0.001). After controlling for compliance with established guidelines, the odds ratio of an event increased by 46% for each unit increase in Rush score (p <0.001). After adjusting for the Rush score, the odds ratio decreased by 54% for each unit increase in compliance (p <0.001). Thus, compliance with current American College of Cardiology/American Heart Association guidelines significantly improves prognosis, regardless of the risk score. The use of established risk scores may overestimate event rates in unselected populations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15464668     DOI: 10.1016/j.amjcard.2004.06.021

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Effect of Xuesaitong soft capsule on hemorrheology and in auxiliarily treating patients with acute cerebral infarction.

Authors:  Shang-qian Zhong; Li-jing Sun; Yu-zhen Yan; Yan-qin Sun; Yin-yuan Zhong
Journal:  Chin J Integr Med       Date:  2005-06       Impact factor: 1.978

2.  Magnitude and consequences of undertreatment of high-risk patients with non-ST segment elevation acute coronary syndromes: insights from the DESCARTES Registry.

Authors:  M Heras; H Bueno; A Bardají; A Fernández-Ortiz; H Martí; J Marrugat
Journal:  Heart       Date:  2006-04-27       Impact factor: 5.994

3.  Understanding factors that influence the use of risk scoring instruments in the management of patients with unstable angina or non-ST-elevation myocardial infarction in the Netherlands: a qualitative study of health care practitioners' perceptions.

Authors:  Josien Engel; Marie-Julie Heeren; Ineke van der Wulp; Martine C de Bruijne; Cordula Wagner
Journal:  BMC Health Serv Res       Date:  2014-09-22       Impact factor: 2.655

4.  A cross-sectional multicentre study of cardiac risk score use in the management of unstable angina and non-ST-elevation myocardial infarction.

Authors:  Josien Engel; Ineke van der Wulp; Martine de Bruijne; Cordula Wagner
Journal:  BMJ Open       Date:  2015-11-24       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.